nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of tumor nuclear features using artificial intelligence to predict response to neoadjuvant chemotherapy in high-risk breast cancer patients
|
Dodington, David W. |
|
|
186 |
2 |
p. 379-389 |
artikel |
2 |
Body composition and breast cancer risk and treatment: mechanisms and impact
|
Iwase, Toshiaki |
|
|
186 |
2 |
p. 273-283 |
artikel |
3 |
Can we rely on surgical clips placed during oncoplastic breast surgery to accurately delineate the tumor bed for targeted breast radiotherapy?
|
Aldosary, Ghada |
|
|
186 |
2 |
p. 343-352 |
artikel |
4 |
Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development
|
Nakashoji, Ayako |
|
|
186 |
2 |
p. 353-361 |
artikel |
5 |
Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients
|
Qi, Peng |
|
|
186 |
2 |
p. 327-342 |
artikel |
6 |
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
|
Sukumar, Jasmine |
|
|
186 |
2 |
p. 569-575 |
artikel |
7 |
Correction to: Behavior of metastatic breast cancer according to subtype
|
Van Mechelen, Margot |
|
|
186 |
2 |
p. 587-589 |
artikel |
8 |
COVID-19 and breast cancer at a Regional Breast Centre: our flexible approach during the pandemic
|
Cadili, Lina |
|
|
186 |
2 |
p. 519-525 |
artikel |
9 |
CTCs-oriented adjuvant personalized cytostatic therapy non-metastatic breast cancer patients: continuous non-randomized prospective study and prospective randomized controlled study
|
Shliakhtunou, Ya A. |
|
|
186 |
2 |
p. 439-451 |
artikel |
10 |
Ductal carcinoma in situ in patients younger than 30 years: differences in adjuvant endocrine therapy and outcomes
|
Halasz, Sasha R. |
|
|
186 |
2 |
p. 551-559 |
artikel |
11 |
(Ex-)breast cancer patients with (pre-existing) symptoms of anxiety and/or depression experience higher barriers to contact health care providers during the COVID-19 pandemic
|
Mink van der Molen, Dieuwke R. |
|
|
186 |
2 |
p. 577-583 |
artikel |
12 |
FOXA1 is a determinant of drug resistance in breast cancer cells
|
Kumar, Uttom |
|
|
186 |
2 |
p. 317-326 |
artikel |
13 |
Heart failure prevention and monitoring strategies in HER2-positive breast cancer: a narrative review
|
Jafari, Lua |
|
|
186 |
2 |
p. 295-303 |
artikel |
14 |
Heregulin-induced cell migration is prevented by trastuzumab and trastuzumab-emtansine in HER2+ breast cancer
|
Mondaca, Joselina Magali |
|
|
186 |
2 |
p. 363-377 |
artikel |
15 |
International variation in breast cancer incidence and mortality in young women
|
Sopik, Victoria |
|
|
186 |
2 |
p. 497-507 |
artikel |
16 |
Meta-analysis and cost-effectiveness of ductoscopy, duct excision surgery and MRI for the diagnosis and treatment of patients with pathological nipple discharge
|
Filipe, M. D. |
|
|
186 |
2 |
p. 285-293 |
artikel |
17 |
Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry
|
Jiagge, Evelyn M. |
|
|
186 |
2 |
p. 391-401 |
artikel |
18 |
Myosteatosis evaluation using erector spinae and psoas muscles to predict adverse events during adjuvant chemotherapy for breast cancer
|
Aleixo, G. F. P. |
|
|
186 |
2 |
p. 487-495 |
artikel |
19 |
New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12)
|
Kim, Jae Sik |
|
|
186 |
2 |
p. 453-462 |
artikel |
20 |
Oleuropein is a natural inhibitor of PAI-1-mediated proliferation in human ER-/PR- breast cancer cells
|
Tzekaki, Elena E. |
|
|
186 |
2 |
p. 305-316 |
artikel |
21 |
Patterns of de-novo metastasis and breast cancer-specific mortality by race and molecular subtype in the SEER population-based dataset
|
Sakhuja, Swati |
|
|
186 |
2 |
p. 509-518 |
artikel |
22 |
Prediction of axillary nodal burden in patients with invasive lobular carcinoma using MRI
|
Ha, Su Min |
|
|
186 |
2 |
p. 463-473 |
artikel |
23 |
Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation
|
Moravek, Molly B. |
|
|
186 |
2 |
p. 429-437 |
artikel |
24 |
Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer
|
Xie, Eric |
|
|
186 |
2 |
p. 561-568 |
artikel |
25 |
RE: Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early stage breast cancer patients
|
Li, Xiao‑Min |
|
|
186 |
2 |
p. 585-586 |
artikel |
26 |
Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature
|
Huang, Ching-Shui |
|
|
186 |
2 |
p. 475-485 |
artikel |
27 |
Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials
|
Goetz, Matthew P. |
|
|
186 |
2 |
p. 417-428 |
artikel |
28 |
Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach
|
Damin, Andrea P. |
|
|
186 |
2 |
p. 527-534 |
artikel |
29 |
Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer
|
Prakash, Ipshita |
|
|
186 |
2 |
p. 535-550 |
artikel |
30 |
Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast
|
Yang, Libo |
|
|
186 |
2 |
p. 403-415 |
artikel |